pharmaphorum October 10, 2024
Phil Taylor

EVERSANA has signed an agreement with Oracle Argus Cloud to add to the features of its pharmacovigilance platform, which helps manufacturers monitor drug safety in an increasingly complex pharmaceutical market.

The partnership has added new functionality to the pharmacovigilance platform, including artificial intelligence-enabled automation, workflow optimisation, and conditional touchless processing which can reduce the manual intervention needed to monitor adverse effects of medicines.

The refinements to its offering are designed to lighten the load of medical affairs teams as they face “increasing caseloads and changing regulations across the life sciences industry,” said pharmaphorum parent EVERSANA in a statement.

The move ties in with the trend in the industry for pharmacovigilance to shift from a reactive activity – which can be...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Cloud, Partnerships, Pharma, Pharma / Biotech, Technology, Trends
Pharma Pulse 3/14/25: Navigating Internal Constraints and Uncertainty, Health Plan Support During Natural Disasters & more
New AI model can estimate a person's true biological age from five drops of blood
Spotiphy AI Tool Enhances Spatial Transcriptomics for Precision Medicine
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
FDA Approves First Biosimilar to Omalizumab

Share This Article